Can SGLT2 inhibitors answer unmet therapeutic needs in chronic kidney disease?

Chronic kidney disease (CKD) is a global health problem, affecting more than 850 million people worldwide. The number of patients receiving renal replacement therapy (dialysis or renal transplantation) has increased over the years, and it has been estimated that the number of people receiving renal...

Descripción completa

Detalles Bibliográficos
Autores principales: De Nicola, Luca, Cozzolino, Mario, Genovesi, Simonetta, Gesualdo, Loreto, Grandaliano, Giuseppe, Pontremoli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300572/
https://www.ncbi.nlm.nih.gov/pubmed/35583597
http://dx.doi.org/10.1007/s40620-022-01336-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300572/
https://www.ncbi.nlm.nih.gov/pubmed/35583597
http://dx.doi.org/10.1007/s40620-022-01336-7

Ejemplares similares